US buyout fund Platinum Equity Advisors is in talks to acquire Mumbai-based contract drugmaker Inventia Healthcare at a valuation of ₹2,500 crore ($300 million). Existing investors InvAscent Capital and Jacob Ballas are set to exit their investments while promoter Janak Shah and family will retain a minority stake. Post the transaction, the promoter family intends to continue leading the company. Rothschild & Co and Stifel Financial Corp are running the sale process of Inventia.
Related Keywords
India , United States , Ambernath , Maharashtra , Mumbai , United Kingdom , American , Amit Sobti , Jacob Ballas , Ankur Shah , Amaya Shah , Janak Shah , Stifel Financial Corp Torreya , Rothschild Co , Drug Administration , Platinum Equity Advisors , Inventia Healthcare , Invascent Capital , Platinum Equity , Stifel Financial Corp , Latin American , Us Fund Platinum , Inventia Health , Promoter Janak Shah ,
vimarsana.com © 2020. All Rights Reserved.